★★★★☆
4.5 étoiles sur 5 de 678 avis
2016-10-28
Data Integrity in Pharmaceutical and Medical Devices Regulation Operations: Best Practices Guide to Electronic Records Compliance - de Orlando Lopez (Author)
Caractéristiques Data Integrity in Pharmaceutical and Medical Devices Regulation Operations: Best Practices Guide to Electronic Records Compliance
Le paragraphe ci-dessous répertorie des spécificités de base concernant Data Integrity in Pharmaceutical and Medical Devices Regulation Operations: Best Practices Guide to Electronic Records Compliance
| Le Titre Du Fichier | Data Integrity in Pharmaceutical and Medical Devices Regulation Operations: Best Practices Guide to Electronic Records Compliance |
| Sortié Le | 2016-10-28 |
| Traducteur | Saad Jory |
| Quantité de Pages | 732 Pages |
| La taille du fichier | 50.32 MB |
| Langue du Livre | Anglais & Français |
| Éditeur | Harvard University Press |
| ISBN-10 | 6424757813-BFW |
| Type de Livre | PDF AMZ ePub LOG TXT |
| de (Auteur) | Orlando Lopez |
| EAN | 177-8040120143-IOU |
| Nom de Fichier | Data-Integrity-in-Pharmaceutical-and-Medical-Devices-Regulation-Operations-Best-Practices-Guide-to-Electronic-Records-Compliance.pdf |
Télécharger Data Integrity in Pharmaceutical and Medical Devices Regulation Operations: Best Practices Guide to Electronic Records Compliance Livre PDF Gratuit
Presentation on US FDA Data Integrity Guidance 1 This presentation is compiled by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional
ESi’s regulatory group for pharmaceutical and medical devices includes experienced employees both exFDA and former industry professionals who provide comprehensive assistance through the manufacturing timeline from presubmission of pharmaceutical NDAANDA and medical device 510k to manufacturing packaging and testing
A lack of Data Integrity hints of a Company being outside of compliance and questions the quality of the product being produced Often the initial “hint” of an offshore problem occurs within FDA “circles” when one first observes an “Import Alert”
Our Intelligent Design Control solution helps medical device companies become datadriven modelbased and document smart by increasing engineering efficiency and speed across the device lifecycle while avoiding costly errors quality issues and recalls
The purpose of 21 CFR Part 11 is to ensure the transparency and reliability of electronic records and electronic signatures in the pharmaceutical industry
Optimize product change management processes at your medical device company for a clear understanding of the data people and processes impacted by change This enables you to effectively plan leverage flexible change processes to meet specific needs and provide full device change traceability